SCHEMBL19475276

SCHEMBL19475276

Nc1ccc(-c2cc(C(=O)N3CCOCC3)c3ccccc3n2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.84
TSHR P16473 3/20 0.84
LMNA P02545 1/20 0.84
POLB P06746 2/20 0.80
KDM4E B2RXH2 2/20 0.80
USP2 O75604 1/20 0.80
TP53 P04637 1/20 0.80
HPGD P15428 1/20 0.80
HSD17B10 Q99714 1/20 0.80
MOK Q9UQ07 1/20 0.72
CYP2C9 P11712 3/20 0.63
CYP3A4 P08684 2/20 0.63
CYP2C19 P33261 2/20 0.63
PLAUR Q03405 2/20 0.63
CYP1A2 P05177 1/20 0.63
RAB9A P51151 1/20 0.60
PKM P14618 1/20 0.60
ATM Q13315 1/20 0.59
RXFP1 Q9HBX9 1/20 0.59
TDP1 Q9NUW8 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10760683 0.92 ALDH1A1 (1.00) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL19475308 0.86 ALDH1A1 (0.69) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL19475493 0.84 MOK (1.00) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL15237515 0.83 ALDH1A1 (0.71) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL19475479 0.83 MOK (0.74) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL19475316 0.82 ALDH1A1 (0.57) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL10757593 0.80 CYP2C9 (0.83) ALDH1A1TSHRLMNAPOLBMOK
SCHEMBL19508806 0.80 ALDH1A1 (0.73) ALDH1A1TSHRLMNAPOLBKDM4E
SCHEMBL10761462 0.79 CYP2C9 (0.86) ALDH1A1TSHRLMNAPOLBMOK
SCHEMBL10609034 0.79 L3MBTL1 (0.58) ALDH1A1TSHRLMNAPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof UNIV NEW YORK (US) 2021-12-07 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF UNIV NEW YORK (US) 2019-06-27 US disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194136-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF AGER, HMGB1, GPR119 ALDH1A1 1885/4885TSHR 2426/4885LMNA 793/4885
US-11192859-B2 Quinoline compounds as modulators of RAGE activity and uses thereof AGER, HMGB1, GPR119 ALDH1A1 1885/4885TSHR 2426/4885LMNA 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.